Details for Patent: 5,863,559

✉ Email this page to a colleague

Summary for Patent: 5,863,559

Patent landscape, scope, and claims:

Title:	Oral dosage form for treating migraine
Abstract:	A pharmaceutical composition for oral adminstration comprising a film-coated solid dosage form including 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide or a pharmaceutically acceptable salt or solvate thereof as active ingredient. The film-coated solid dosage forms are of use in the treatment of conditions associated with cephalic pain, in particular migraine.
Inventor(s):	Phillips; Anthony John (Ware, GB3), Winterborn; Ian Keith (Mississauga, CA), Padfield; John Malcolm (Uxbridge, GB3)
Assignee:	Glaxo Group Limited (Greenford, GB2)
Application Number:	08/381,422
Patent Claim Types: see list of patent claims	Composition; Compound; Dosage form; Use;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 5,863,559

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 5,863,559

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	9104890	Mar 08, 1991

PCT Information
PCT Filed	March 02, 1992	PCT Application Number:	PCT/EP92/00460
PCT Publication Date:	September 17, 1992	PCT Publication Number:	WO92/15295

International Family Members for US Patent 5,863,559

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	165973	⤷ Subscribe
Australia	1326492	⤷ Subscribe
Australia	663303	⤷ Subscribe
Belgium	1005086	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.